<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>'Latent autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> in adults' (LADA) is the term coined to describe adults who have a <z:hpo ids='HP_0003677'>slowly progressive</z:hpo> form of autoimmune or type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> that can be treated initially without insulin injections </plain></SENT>
<SENT sid="1" pm="."><plain>The diagnosis of LADA is currently based on three clinical criteria: (1) adult age at <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:mp ids='MP_0002055'>diabetes</z:mp>; (2) the presence of circulating islet autoantibodies, which distinguishes LADA from type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>; and (3) insulin independence at diagnosis, which distinguishes LADA from classic type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>The prevalence of LADA in adults presenting with non-insulin-requiring <z:mp ids='MP_0002055'>diabetes</z:mp> is approximately 10% </plain></SENT>
<SENT sid="3" pm="."><plain>Recognition of LADA expands the concept and prevalence of autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp>, but LADA remains poorly understood at both a clinical and research level </plain></SENT>
<SENT sid="4" pm="."><plain>In this perspective, we review the nomenclature, diagnostic criteria, genetics, pathology and therapy of LADA, to arrive at recommendations that might advance knowledge and management of this form of <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>